Showing results (1-10 of 329) with videos related to
Sort By:
Pageof 33
Diabetes/Metabolism Research and Reviews|September 27, 2002
Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPEHertzel C GersteinEndocrinology and Metabolism Clinics of North America|September 14, 2002
Epidemiologic analyses of risk factors, risk indicators, risk markers, and causal factors. The example of albuminuria and the risk of cardiovascular disease in diabetesHertzel C GersteinNature Reviews. Endocrinology|May 16, 2009
Is it possible to reduce cardiovascular risk with glucose-lowering approaches?Hertzel C GersteinEndocrinology and Metabolism Clinics of North America|March 9, 2005
Insulin therapy in people who have dysglycemia and type 2 diabetes mellitus: can it offer both cardiovascular protection and beta-cell preservation?Hertzel C Gerstein, Julio RosenstockEndocrinology and Metabolism Clinics of North America|February 7, 2018
Cardiovascular Outcomes Trials of Glucose-Lowering Drugs or Strategies in Type 2 DiabetesHertzel C Gerstein, Reema ShahCirculation|July 6, 2026
Cardiovascular Risk Reduction With GLP-1 RA DrugsMarie Pigeyre, Hertzel C GersteinSeminars in Vascular Medicine|October 14, 2005
Dysglycemia: a key cardiovascular risk factorHertzel C Gerstein, Sarah E CapesCanadian Journal of Diabetes|May 28, 2021
Insulin Therapy: The Discovery That Shaped a CenturyHertzel C Gerstein, Christopher J RuttyThe Lancet. Diabetes & Endocrinology|March 14, 2014
Dysglycaemia, vasculopenia, and the chronic consequences of diabetesHertzel C Gerstein, Geoff H WerstuckJournal of Diabetes|December 8, 2022
Are U-shaped relationships between risk factors and outcomes artifactual?Reema Shah, Lehana Thabane, Hertzel C GersteinPageof 33